The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice.
about
The mGluR2/3 agonist LY379268 blocks the effects of GLT-1 upregulation on prepulse inhibition of the startle reflex in adult rats.Realistic expectations of prepulse inhibition in translational models for schizophrenia research.Trace amine-associated receptor 1-Family archetype or iconoclast?Animal models of attention-deficit hyperactivity disorder.Animal models of tic disorders: a translational perspective.Annual Research Review: Transgenic mouse models of childhood-onset psychiatric disorders.Prepulse inhibition and genetic mouse models of schizophrenia.A translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacyPharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.The reelin receptors VLDLR and ApoER2 regulate sensorimotor gating in mice.Cross-species assessments of motor and exploratory behavior related to bipolar disorder.Implications of genome wide association studies for addiction: are our a priori assumptions all wrong?Effects of atomoxetine on hyper-locomotive activity of the prenatally valproate-exposed rat offspringA reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern MonitorKnocking out the dopamine reuptake transporter (DAT) does not change the baseline brain arachidonic acid signal in the mouse.Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder?The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in ratsRole of the serotonin system in ADHD: treatment implications.Dopamine transporter mutant animals: a translational perspective.Transgenic mouse models for ADHD.Atypical antipsychotics clozapine and quetiapine attenuate prepulse inhibition deficits in dopamine transporter knockout mice.New therapeutic potential for psychoactive natural products.The dopamine transporter role in psychiatric phenotypes.Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.Dissociations between interval timing and intertemporal choice following administration of fluoxetine, cocaine, or methamphetamine.An evaluation of the serotonin system and perseverative, compulsive, stereotypical, and hyperactive behaviors in dopamine transporter (DAT) knockout mice.Mechanism Exploration of Arylpiperazine Derivatives Targeting the 5-HT2A Receptor by In Silico Methods.GBR 12909 administration as an animal model of bipolar mania: time course of behavioral, brain oxidative alterations and effect of mood stabilizing drugs.Using affect-modulated startle to study phenotypes of pediatric bipolar disorder.Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings
P2860
Q24603020-9C4B8E80-A8CF-4E2D-BB55-0AB48347AA33Q24645703-0078B0C3-F637-497B-ABBA-AE8C9AAC46A7Q24648659-1A1B9F47-D007-4DCE-91E1-519E3C75E947Q24814868-4F09D5CE-CBA4-4C5C-BF7B-6A5A8850D1E4Q30395243-6677C7DB-C535-428D-9B67-9E3EF913B4B9Q30469044-33ED2E29-140D-49DE-8C64-9B1E64357388Q30478270-72B29189-6463-43A5-993B-28B08E17BED2Q30485065-40479289-0435-42F8-AD55-AA00CC026680Q30493133-FA8CD461-BF2A-4078-93F1-45C756033854Q30496781-87B07AD9-26F7-493B-B39D-7F9A6A7666B6Q33976551-2AE06174-5EAC-46B2-BED2-350199887FB6Q34358797-887326AD-7138-4CAD-8467-9772A2B6BEA2Q34360515-B49B4900-8088-4D06-94C9-29609215D1A4Q36069708-784E0C59-215D-4E91-A472-FB3322464438Q36296926-7642BB3D-A532-49E4-A83D-DE085A041D47Q36517227-642B4B65-E7FE-41CC-939C-CCC3AC3753E7Q36534965-AA7DDD27-9444-4D6C-8768-D17B2721BCA2Q36972698-85773BC0-678A-47CB-B47E-6B099BE2FACDQ36992394-14EB8B58-CDE5-46B9-80D7-75B579E2EF20Q37203801-1A1885E8-3160-4CB9-9BC4-0D9495D12728Q37219082-E30A0459-E9B7-45F7-B277-79FAD55D0D33Q37660087-07BE68CB-C81C-4F3D-A6E2-285BB78CAC9FQ38648135-E6F11A4A-E66B-4B97-918B-A7BF4C8F6502Q38926644-B54AC96A-7AF7-4351-AB55-A8EFD3197578Q42719797-7238059F-0EE3-4156-8B61-D778BFBE698CQ44022234-7A3B2BDD-8113-4C08-9A7B-4C6A02FC1EB6Q47573081-35790CF1-65BF-4B57-94D7-07ECA13B2A44Q47685038-367FCF79-22DE-4A03-A20A-0DEC54DED2CEQ50949150-88DBD13F-6D0E-4523-B37F-FAD72928D012Q59292055-568168E1-7FB3-4489-BA4F-603F47076C40
P2860
The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
The selective serotonin-2A rec ...... ine transporter knockout mice.
@en
The selective serotonin-2A rec ...... ine transporter knockout mice.
@nl
type
label
The selective serotonin-2A rec ...... ine transporter knockout mice.
@en
The selective serotonin-2A rec ...... ine transporter knockout mice.
@nl
prefLabel
The selective serotonin-2A rec ...... ine transporter knockout mice.
@en
The selective serotonin-2A rec ...... ine transporter knockout mice.
@nl
P2093
P2860
P921
P356
P1476
The selective serotonin-2A rec ...... mine transporter knockout mice
@en
P2093
Marc G Caron
Mark A Geyer
Martin Paulus
Virginia Lehmann-Masten
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300343
P407
P577
2004-02-01T00:00:00Z